Last reviewed · How we verify
NCT06966297: MSOT_PI
MSOT_PI Analysis of Revascularization Procedure Using Optoacoustic Imaging
trial testing Multispectral optoacoustic tomography in PAD in 40 participants. Completed in 1 March 2025.
10 February 2025
Quick facts
| Lead sponsor | University Hospital Erlangen |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 40 |
| Start date | 1 March 2024 |
| Primary completion | 10 February 2025 |
| Estimated completion | 1 March 2025 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Multispectral optoacoustic tomography
Conditions studied
- PAD — all drugs for PAD →
- Vascular Diseases — all drugs for Vascular Diseases →
Sponsor
University Hospital Erlangen
Who can join
18 and older, any sex, with PAD or Vascular Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the proposed study is to analyse the improvement of the calf muscle perfusion of patients with PAD Fontaine stage II and critical limb threatheaning ischemia (CLTI) after endovascular and surgical revascularization procedures using multispectral optoacoustic tomography (MSOT)
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06966297
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Multispectral optoacoustic tomography
Trials testing the same drug.
- NCT05935839 — Tissue Changes in Diabetes in Adults and Children Using Multispectral Optoacoustic Tomography. · NA · unknown
- NCT06740175 — The Feasibility of Multispectral Optoacoustic Tomography in Different Diseases · NA · completed
Other recruiting trials for PAD
Currently open trials in the same condition.
- NCT07130526 — Distrupt Stiffness Trial · NA · recruiting
- NCT05345431 — Endovascular Denervation for the Treatment of Patients With Peripheral Arterial Disease · NA · recruiting
- NCT04788914 — lncRNAs as a Biomarker to Assess the Therapeutic Impact of Oral Absorbent ± Probiotics in CKD Patients With PAD · NA · recruiting
Other University Hospital Erlangen trials
Trials by the same sponsor.
- NCT07347535 — Non-invasive MSOT Examination of Muscle Oxygenation in Athletes and PAD Patients · not yet recruiting
- NCT06994260 — Diagnostic Imaging of Vascular Malformations Using MSOT and ULM · not yet recruiting
- NCT05773547 — Investigation of the Learning Effect in the Measurement of Circulation in Calf Muscle Using MSOT · unknown
- NCT05110677 — Pilot Study of Topographic Imaging of the Calf Muscle in Patients With PAD Using 3D Reconstruction of MSOT Images · unknown
- NCT04641091 — Muscle Perfusion in Patients With PAD by Non-invasive MSOT · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06966297 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital Erlangen
- Last refreshed: 15 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06966297.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing